Annual Drug Patent Expirations for SUMAVEL+DOSEPRO Sumavel Dosepro is a drug marketed by Endo Ventures Ltd and is included in one NDA. There are six patents protecting this drug. SUMAVEL…
The post New patent expiration for Endo Ventures drug SUMAVEL DO…
New patent expiration for Endo Ventures drug SUMAVEL DOSEPRO Read Post »
This chart shows the companies which have received the most New Product exclusivities in the past five years. New Product Development is one of the categories for which the FDA…
The post Pharmaceutical companies with the most ‘New Product Exclusivity’ …
Pharmaceutical companies with the most ‘New Product Exclusivity’ drugs Read Post »
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Taiho Oncology drug LONSURF appeared first on DrugPat…
This chart shows the patent expirations for suspension dosed drugs over the next decade. The term of drug patents varies. The basic term for a patent is 20 years from…
The post Suspension dosed drug patent expirations by year appeared first on DrugPate…
Suspension dosed drug patent expirations by year Read Post »
A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding. The article sheds…
The post Prevalence and timing of au…
Prevalence and timing of authorized generics in the US market Read Post »
SIGNIFOR LAR KIT (pasireotide pamoate) Recordati rare Patent: 8,822,637 Expiration: Aug 6, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for …
Drug Patent Expirations for the Week of August 6, 2023 Read Post »
Pharmaceutical drug patents enable branded drug companies to prevent market entry by competitors until the patents expire. The term of drug patents varies. The basic term for a patent is…
The post Future drug patent expirations by year appeared first o…
A recent update from Foley & Lardner attorney Courtenay C. Brinckerhoff discusses trends in Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings involving Orange Book and biologic patents, based…
The post Insights into Shifting Dynamics: O…
Insights into Shifting Dynamics: Orange Book and Biologic PTAB Trends Read Post »
This chart shows the pharmaceutical companies with the most patents in Bulgaria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pat…
Which pharmaceutical companies have the most drug patents in Bulgaria? Read Post »
Annual Drug Patent Expirations for SIGNIFOR+LAR+KIT Signifor Lar Kit is a drug marketed by Recordati Rare and is included in one NDA. It is available from one supplier. There are…
The post New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT …
New patent expiration for Recordati Rare drug SIGNIFOR LAR KIT Read Post »
Get new actionable insights and updates from BiotechBlog
